Icahn Builds Small Position in Allergan

Source: Bloomberg

Carl Icahn has built a small position in Allergan, according to people familiar with the matter, as the drugmaker plans to spin off its women’s health and antibiotic divisions, as reported in Bloomberg.

Icahn’s motivation and the size of his investment remain unclear, said the people, who asked not to be identified because the matter is private. Icahn previously held a position in Allergan, disclosing a stake in 2016 that was sold in the first quarter of 2017, according to data compiled by Bloomberg.

Read the full article.

Related Content